Delivery Order SPE2DB22D3301-SPE2DB24FZ4EK
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.51 firm fixed-price delivery order is for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,834.97 firm fixed-price delivery order is for Gadavist 10 mmol/10 ml vials. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,711.35 Delivery Order contract is for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, which is a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 10, 2024.
Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,608.22 firm fixed price delivery order is for the supply of Gadavist, a medical imaging agent, with a completion date of May 30, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Gadavist, a medical contrast agent, in 30 ml vials. The award, valued at $1,140.90, is a firm fixed-price delivery order contract with a completion date of May 29, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $6,796.40 firm-fixed-price contract is for the supply of 10 milliliter vials of the pharmaceutical product Gadavist, with a performance period through August 15, 2024. AmerisourceBergen is a large pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and healthcare programs, including the military....
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $5,749.28 firm fixed-price delivery order is for the supply of Gadavist 10 MMOL/10 ML Vial 10ML, with a final completion date of August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and...
The federal contract award is for the delivery of Gadavist (10 mL syringes) to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,159.59 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024. The contract has an ultimate completion date of October 29, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Gadavist 10 mmol/10 ml vial 10 ml. The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,337.79 firm fixed-price delivery order is for the supply of 4565188888 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has an ultimate completion date of July 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...